Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma

NCT00546143 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis